Friendly” labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...

US FDA review finds no evidence linking GLP-1 receptor agonists in popular medicines like Wegovy and Zepbound to an increased ...

The warnings, part of their original approval, were based ​on reports of such events observed with a variety of older ...

Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and body composition monitoring.

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...

In the past few months, court records show dozens of lawsuits filed by patients in Marion County against Indianapolis-based ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...